We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
264 hedge funds and large institutions have $2.62B invested in Acadia Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 109 increasing their positions, 80 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more call options, than puts
Call options by funds: $13.5M | Put options by funds: $6.12M
36% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 80
3% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 39
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.54% less ownership
Funds ownership: 98.1% → 97.56% (-0.54%)
1% less funds holding
Funds holding: 267 → 264 (-3)
12% less capital invested
Capital invested by funds: $2.99B → $2.62B (-$369M)
Holders
264
Holders Change
-3
Holders Change %
-1.12%
% of All Funds
3.81%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
40
Increased
109
Reduced
80
Closed
39
Calls
$13.5M
Puts
$6.12M
Net Calls
+$7.34M
Net Calls Change
+$3.87M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$47.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$36.3M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$21.9M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$15.8M |
| 5 |
Morgan Stanley
New York
|
+$15M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$75M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$49.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.3M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$16.7M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$13.6M |
